In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including ...

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

These days, the frontier AI labs are all racing to build self-improving models. Some believe it’s the surest route to ...

An updated edition of the May 18, 2026, article. The global oncology market is evolving rapidly, fueled by rising cancer incidence, an aging population and continued scientific innovation. According ...

Amazon Mechanical Turk shutdown ends 21 years of invisible labor that powered the AI training industry, as AWS closes the ...

Model collapse AI training data risk grows as Meta’s Brand Memory ad tools flood the open web with synthetic content, ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

Velo3D, Inc. ("Velo3D"), a leading metal additive manufacturing technology company, today announced that Mears Machine Corporation ("Mears") has ordered its fifth Velo3D Sapphire® XC metal additive ...

Artificial intelligence is rewriting the world and simultaneously inventing a whole new language to describe how it’s doing it. Sit in on any product meeting, pitch, or panel these days, and you’ll ...